Rhythm Biosciences Limited (RHY.AX)
AUD 0.08
(-3.53%)
AUD 0.08
(-3.53%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 5.34 Million AUD | -53.65% |
| 2023 | 11.54 Million AUD | 2.63% |
| 2022 | 11.24 Million AUD | 45.42% |
| 2021 | 7.73 Million AUD | 85.84% |
| 2020 | 4.16 Million AUD | 12.02% |
| 2019 | 3.71 Million AUD | 128.1% |
| 2018 | 1.62 Million AUD | 2158.01% |
| 2017 | 72.12 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q4 | 2.68 Million AUD | 0.0% |
| 2024 Q2 | 5.71 Million AUD | 0.0% |
| 2024 FY | 8.39 Million AUD | -27.24% |
| 2023 Q4 | 4.93 Million AUD | 0.0% |
| 2023 Q2 | 6.41 Million AUD | 0.0% |
| 2023 FY | 11.54 Million AUD | 2.63% |
| 2022 Q2 | 6.6 Million AUD | 0.0% |
| 2022 FY | 11.24 Million AUD | 45.42% |
| 2022 Q4 | 4.54 Million AUD | 0.0% |
| 2021 Q2 | 3.05 Million AUD | 29292.07% |
| 2021 FY | 7.73 Million AUD | 85.84% |
| 2021 Q1 | 10.38 Thousand AUD | -99.52% |
| 2021 Q4 | 4.53 Million AUD | 0.0% |
| 2020 Q4 | 2.14 Million AUD | 20557.52% |
| 2020 FY | 4.16 Million AUD | 12.02% |
| 2020 Q2 | 1.87 Million AUD | 0.0% |
| 2020 Q3 | 10.38 Thousand AUD | -99.45% |
| 2019 Q2 | 1.83 Million AUD | 0.0% |
| 2019 FY | 3.71 Million AUD | 128.1% |
| 2019 Q4 | 1.83 Million AUD | 8163.29% |
| 2019 Q3 | 22.24 Thousand AUD | -98.79% |
| 2018 Q2 | 683.62 Thousand AUD | 0.0% |
| 2018 Q3 | 4709.25 AUD | -99.31% |
| 2018 Q4 | 1.13 Million AUD | 23987.23% |
| 2018 FY | 1.62 Million AUD | 2158.01% |
| 2017 FY | 72.12 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Australian Clinical Labs Limited | 81.54 Million AUD | 93.44% |
| BCAL Diagnostics Limited | 8.54 Million AUD | 37.394% |
| Genetic Signatures Limited | 4.3 Million AUD | -24.184% |
| Genetic Technologies Limited | 3.9 Million AUD | -37.019% |
| Healius Limited | 265.1 Million AUD | 97.982% |
| Imagion Biosystems Limited | 15.53 Million AUD | 65.561% |
| Integral Diagnostics Limited | 61.88 Million AUD | 91.356% |
| INOVIQ Ltd | 6.8 Million AUD | 21.404% |
| Microba Life Sciences Limited | 5.9 Million AUD | 9.408% |
| Monash IVF Group Limited | 91.1 Million AUD | 94.128% |
| Sonic Healthcare Limited | 1.49 Billion AUD | 99.642% |